PHARMACEUTICAL PREPARATIONS PROTECTION AGAINST
| Brand | Owner (click to sort) | Address | Description |
|---|---|---|---|
| MT PHARMA | Mitsubishi Tanabe Pharma Corporation | 3-2-10, Dosho-machi Chuo-ku, Osaka-shi Osaka 541-8505 Japan | Pharmaceutical preparations for protection against free radicals; pharmaceutical preparations for removing free radicals from the human bodies; pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS); neuroprotective medicines; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; antiallergic medicines; antihypertensives; hypoglycemic agents; antidiabetic preparations; pharmaceutical preparations for the prevention of diabetic nephropathy; pharmaceutical preparations, namely, antiphlogistic agents; vaccine; pharmaceutical preparations for the treatment of autoimmune disease; pharmaceutical preparations for the treatment of cerebral infarction; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of erectile dysfunction;PHARMA; |
| NEUMUNE | Hollis-Eden Pharmaceuticals, Inc. | Suite 400 4435 Eastgate Mall San Diego CA 921211980 | pharmaceutical preparations for protection against and treatment of side effects of radiation, radio- and chemotherapeutic treatments, and other diseases and disorders, and also immune modulation; |
| OPEN UP THE FUTURE | Mitsubishi Tanabe Pharma Corporation | 3-2-10, Dosho-machi Chuo-ku, Osaka-shi Osaka 541-8505 Japan | Pharmaceutical preparations for protection against free radicals; pharmaceutical preparations for removing free radicals from the human bodies; pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS); neuroprotective medicines; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; antiallergic medicines; antihypertensives; hypoglycemic agents; antidiabetic preparations; pharmaceutical preparations for the prevention of diabetic nephropathy; pharmaceutical preparations, namely, antiphlogistic agents; vaccine; pharmaceutical preparations for the treatment of autoimmune disease; pharmaceutical preparations for the treatment of cerebral infarction; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of erectile dysfunction;Color is not claimed as a feature of the mark.; |
| PHOSPHONOL | Hollis-Eden Pharmaceuticals, Inc. | Suite 400 4435 Eastgate Mall San Diego CA 921211980 | pharmaceutical preparations for protection against and treatment of mutagenesis, radiation injury, side-effects of radiation therapy and chemotherapy, and carcinogenesis; |
Where the owner name is not linked, that owner no longer owns the brand |
Technical Examples
- The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.